retatrutide 2025 trial results This is exciting. 👀 The TRIUMPH-4 for Lilly's investigational medication were released, showing weight loss of up to 71 lbs (~28%) over 68 weeks in the highest-dose group—far beyond October 27, 2025: U.K. regulators

Buyers should ask their assigned provider directly about the specific medication, dosage protocol, and titration schedule before starting - because the titration timeline (how quickly your dose increases toward a therapeutic target) affects both tolerability and expected timeline to meaningful weight change

A pesar de la baja incidencia de estos eventos adversos y de la probabilidad de que los beneficios superen estos riesgos en los individuos con obesidad grave, los mdicos y los pacientes deben ser conscientes de estos efectos secundarios graves

These results are very promising, but TRIUMPH-4 included people with knee osteoarthritis, so the results may not apply exactly to every person using retatrutide for weight loss

Sjolund K, Sanden G, Hakanson R, Sundler F

What GLP-1 treatments work

Dual Hormone Action: Tirzepatide activates GLP-1 and GIP receptors